Results
in p50 and thus appears to result from the degradation of p105, as previously suggested (Harhaj et al., 1996) , rather than processing to p50. These findings suggested NF-B p105 and p50 Do Not Exhibit a Classical Precursor-Product Relationship in Pulse-Chase that the generation of p50 may be closely linked with translation.
Radiolabeling Studies
Earlier studies suggested a precursor-product relationship between p105 and p50 either in the absence (Fan A Nascent but Not Folded 497-Amino Acid Fragment of p105 Is Sufficient to Generate p50 and Maniatis, 1991) or presence of mitogen stimulation (Mercurio et al., 1993; Donald et al., 1995; Rousset et Although the C-terminal portion of p105 can be substituted with foreign sequences without affecting p50 genal., 1996) . However, the generation of p50 was slow and substantial quantities of p50 were evident before the eration (Betts and Nabel, 1996; Lin and Ghosh, 1996) , we tested whether the same 497-amino acid fragment initiation of chase in these studies. To assess the relationship between p105 and p50 further, we performed used in in vitro translation was processed in vivo. Surprisingly, even though the full-length 497-amino acid pulse-chase radiolabeling experiments in CHO-CD14 cells transfected with a mouse p105 cDNA expression protein was stably expressed in CHO-CD14 cells and p105 was normally processed to p50 ( Figure 2B , lane vector, harvesting multiple samples during both pulse and chase periods ( Figure 1A ). Increasing amounts of 1), virtually no p50 was generated from p-497 ( Figure  2B , lane 2). This lack of processing of the 497-amino acid both p105 and p50 were readily detected at each of pulse radiolabeling time points (lanes 1-3). Even though fragment in vivo thus differed sharply from the results obtained with this same fragment in vitro ( Figure 1B ). p105 levels declined during the 6 hr chase period, no corresponding increase in p50 radiolabeling was deBoth vectors expressed the same 497-amino acid polypeptide; however, p-497 contained a stop codon followtected (lanes 4-7). Similarly, in pulse-chase studies performed in vitro using rabbit reticulocyte lysates proing residue 497, while the mRNA used in in vitro expression was truncated by restriction of the DNA template grammed with mRNA encoding a 497-amino acid fragment of p105, we observed essentially simultaneous with XhoI prior to transcription. To determine whether the observed differences in p50 radiolabeling of p50 and the larger polypeptide during the initial pulse radiolabeling phase ( Figure 1B , lanes generation in vivo and in vitro reflected the presence or absence of a stop codon, the p-497/XhoI fragment was 3-5). Additionally, the radiolabel present in the 497-amino acid protein did not chase to p50 during the subreengineered with a stop codon (p-497/Stop) and tested for p50 generation in vitro. As shown in Figure 2C (lane sequent 6 hr incubation period. Densitometric analyses of the production of p50 in these in vitro ( Figure 1C ) and 2), the 497-amino acid protein translated from an mRNA containing a stop codon yielded little p50. In contrast in vivo (data not shown) studies indicate that p50 is rapidly generated during the pulse period but only slowly and as shown previously, significant amounts of p50 were generated from mRNA derived from the p-497/ accumulates during the subsequent chase. The disappearance of p105 during the chase phase of the in vivo XhoI vector ( Figure 2C , lane 1). These findings are revealing because in the absence studies ( Figure 1A) was not accompanied by an increase The fragment contains the glycine-rich region (GRR) and spans beyond the estimated C terminus of p50 located at residue 433. (B) Expression and processing of p105 versus the 497-amino acid N-terminal fragment of p105 in vivo. T7 gp10 epitope-tagged p105 and p-497 were transfected into CHO-CD14 cells and radiolabeled as described in Figure  1 . Lysates were prepared and immunoprecipitated. Lane 1, wild-type p105; lane 2, the 497-amino acid fragment of p105; lane 3, control cells transfected with empty vector. (C) In vitro translation of the p105-derived 497-amino acid fragment from mRNAs either lacking or containing a translation stop codon. The two mRNAs derived from p-497/ XhoI (lane 1, lacking a stop codon) or p-497/ Stop (lane 2, containing a stop codon) were translated in rabbit reticulocyte lysates, and the protein products from both translations were immunoprecipitated with anti-p105 specific antisera. Lane 3, immunoprecipitation of control lysates not programmed with mRNA. (D) The Hsc70 chaperone binds to the nascent but not folded form of the 497-amino acid fragment of p105. mRNAs lacking (lane 1) or containing (lane 2) a stop codon following the N-terminal 497 amino acids of p105 were translated in rabbit reticulocyte lysates. Translation was synchronized by the addition of ATCA (75 mM, final concentration) 3 min after initiation. The arrow indicates coimmunoprecipitation of the 497-amino acid fragment of p105 translated from an mRNA lacking a stop codon by antibodies specific for Hsc 70.
of a stop codon, the ribosome stalls at the end of the allow the generation of p50. To determine how much additional translation is required for p50 production, we mRNA and the nascent polypeptide remains bound to the ribosome as a peptidyl tRNA (Krieg et al., 1989) . In moved the stop codon progressively downstream of residue 497 and tested these p105-derived fragments addition, this peptide fails to undergo posttranslational folding (Frydman et al., 1994) . Elimination of stop codons in vivo ( Figure 3B ) and in vitro ( Figure 3C ) for p50 production. An overview of p105 with various landmarks is has been used to study the folding of nascent polypeptides and their interactions with molecular chaperones provided in Figure 3A . As expected, p105 mRNAs terminating after residue 481 or 497 did not support p50 (Frydman et al., 1994; Hansen et al., 1994; Frydman and Hartl, 1996; Komar et al., 1997) . To verify that the generation ( Figure 3B , lanes 2 and 3). Similarly, repositioning of the stop codon following residue 504, 509, or 497-amino acid fragment lacking the stop codon was in a nascent state, aurintricarboxylic acid (ATCA) syn-514 did not lead to significant p50 production in vivo ( Figure 3B , lanes 4-6). However, introduction of the stop chronized in vitro translations (Stewart et al., 1971; Frydman et al., 1994) were performed and the protein prodcodon after residue 530 or further downstream resulted in significant p50 accumulation (lanes 7-9). When a simiucts immunoprecipitated with an antibody specific for the Hsc70 chaperone. Hsc70 exhibits high affinity for lar "stop codon scan" was carried out in vitro, insertion of the stop codon after residue 514 supported p50 gennascent or unfolded polypeptides but binds poorly to folded proteins (Beckmann et al., 1990) . As shown in eration ( Figure 3C , lane 3). We suspect that the different boundaries obtained in the in vivo and in vitro assays Figure 2D , the anti-Hsc70 coimmunoprecipitated the 497-amino acid fragment derived from p-497/XhoI but (residue 530 vs. 514) may stem from the slower rate of translation and protein folding that occurs in vitro. Of did not coimmunoprecipitate the 497-amino acid fragment produced from p-497/Stop. The anti-Hsc70 antinote, Fan and Maniatis (1991) similarly observed that a human p105 deletion mutant terminating at residue 504 body also did not coimmunoprecipitate the p50 protein generated from the nascent 497-amino acid fragment failed to generate p50 in transfected COS cells. Together, these results indicate that in the natural situation, ( Figure 2D , lane 1), suggesting that this product is rapidly folded. Together, these results indicate that premature continuing translation to a point approximately 100 amino acids beyond the C terminus of p50 (residue 433; Lin release and folding of a 497-amino acid fragment of p105 abolishes the generation of p50. In contrast, the and Ghosh, 1996) is required for the generation of p50. same polypeptide efficiently generates p50 if it remains nascent.
p50 Is Generated Prior to Completion of Translation of Full-Length p105
To test further the possibility of cotranslational producTranslation beyond Amino Acid 497 of p105 Permits the Generation of p50 tion of p50, ATCA synchronized in vitro translations were performed for specific periods of time, followed by the Since wild-type p105 generates p50, we reasoned that continuing translation beyond amino acid 497 should addition of puromycin to interrupt further translational elongation (Blobel and Sabatini, 1971) . To separate p50 p105-derived fragment. Similar results were obtained using a 781-amino acid fragment of p105 (data not generation and the completion of translation temporally, a 646-amino acid version of p105 and a translation temshown). perature of 25ЊC were selected. Under these conditions, translation proceeded at an average rate of 60 amino Cotranslational Biogenesis of p105 and p50 acids per min, similar to that observed in prior studies Is Influenced by Sequences Located with luciferase (Frydman et al., 1994) . In these synchroDownstream of the GRR nized translations, p50 production was observed at 9
In most cells, p105 and p50 are produced in nearly equivmin, indicating the synthesis of approximately 540 alent amounts Lin and Ghosh, amino acids (Figure 4, lane 7) . In contrast, translation 1996). Similarly, the nascent 497-amino acid fragment of the larger 646-amino acid fragment required approxiis not completely processed to p50 but rather yields a mately 11 min ( Figure 4 , lane 10). Thus, the generation roughly balanced ratio of the two proteins ( Figure 2C , of p50 occurs well before complete synthesis of the lane 1). This incomplete processing raises the possibility that this process may be stochastic in nature. Since folding of nascent polypeptides occurs cotranslationally and the N-terminal portion of a protein may adopt a native conformation before the completion of C-terminal synthesis (Komar et al., 1997) , it seemed possible that such cotranslational folding of p105 might influence the ratio of the products generated. A prior study has shown that replacement of the entire C terminus of p105 with T7 gp10 or IB-␣ enhances p50 generation (Lin and Ghosh, 1996) . To test whether sequences immediately surrounding the C terminus of p50 (approximately residue 433) might influence the ratio of p50 and p105 production, we fused the N-terminal region of either the T7 gp10 or the IB-␣ genes to the GRR ending at residue differences in p50 generation reflected different reactivto the biologically active form of this inhibitor (Dick et al., 1996 (Dick et al., , 1997 . The addition of clasto-lactacystin ␤-lactone ity of the chimeras with the anti-p50 antibody, the extracts from the p50/⌬gp10 and p50/⌬IB-␣ transfected at concentrations as low as 10 M inhibited the generation of p50 while not altering the production of p105 cells were immunoblotted with antibodies specific for gp10 and IB-␣, respectively ( Figures 5C and 5D ). These ( Figure 6 , compare lanes 1-4 with lanes 5-8). When added at the same concentration, clasto-lactacystin studies confirmed enhanced generation of p50 with both chimeric proteins (compare lane 2 of Figure 5B with ␤-lactone also inhibited LPS-induced degradation of IB-␣ in the CHO-CD14 cells (data not shown). Figures 5C and 5D ). Thus, changing the amino acid in the 96-amino acid segment that adjoins the GRR and
To detect a potential direct interaction of p105 with the proteasome, CHO-CD14 cells were transfected with encompasses the C terminus of p50 and additional downstream sequences likely alters the folding of this p105, p-497, or p50 expression vectors containing a T7 gp10 immunoepitope followed by pulse radiolabeling region and influences the stochastic process that determines the ratio of p50 and p105 produced.
with [ 35 S]methionine/cysteine for 1 hr and chasing for 30 min. Radiolabeling was performed both in the presence and absence of the MG115 proteasome inhibitor.
The 26S Proteasome Mediates Cotranslational Processing of p105
The lysates from these transfections were immunoprecipitated either with anti-gp10 or E446-1, an antibody We next examined the involvement of the 26S proteasome in the cotranslational generation of p50. Producthat reacts with the 20S proteasome. As shown in lane 8 of Figure 7 , E446-1 effectively coimmunoprecipitated tion of p50 was studied in the presence of a Streptomyces noursei-derived metabolite lactacystin, which is a p105 but very little p50. However, newly synthesized p50 encoded by a p50 expression vector was effectively highly specific proteasome inhibitor (Fenteany et al., 1994; Jensen et al., 1995; Craiu et al., 1997) . The potent coimmunoprecipitated by the E446-1 antibody (lane 12), suggesting that the interaction of p105 fragments with clasto-lactacystin ␤-lactone derivative of lactacystin was used in these experiments because it corresponds the proteasome may occur during translation. The 497- ical association of p105 with the proteasome persists in the presence of the MG115 inhibitor (lanes 1-6), sugof translation is likely the critical factor. Continuing gesting that the binding of p105 is independent of the translation to amino acid 530, like the absence of a stop proteolytic activity of the proteasome.
codon, maintains an extended region in the nascent polypeptide for a sufficient period of time to allow proDiscussion teasome processing to p50 (see model in Figure 8B ). Third, to confirm the cotranslational nature of this pro-NF-B p50 Is Cotranslationally Generated cess, we demonstrated in synchronized in vitro translaby the 26S Proteasome tion studies that p50 was produced prior to the compleSeveral lines of evidence have emerged from our studies tion of translation of the full-length protein (Figure 4 ). indicating that p50 is generated by a cotranslational Finally, in sucrose gradient sedimentation studies, the mechanism. First, ribosome halting produced by elimiin vitro translated nascent full-length polypeptides were nation of the stop codon in an mRNA encoding a 497-detected in the dense ribosome-containing fractions, amino acid fragment of p105 results in significant prowhereas p50 was present in the less dense top fractions, duction of p50. In contrast, introduction of a stop codon indicating that p50 was generated while the full-length into this same mRNA sharply inhibits p50 generation fragment was still a peptidyl-tRNA (data not shown). (Figure 2 ). These findings suggest that retention of the Our studies have clearly implicated the 26S protea-497-amino acid polypeptide on the ribosome suspends some in this cotranslational processing event. Addition the polypeptide in an extended, relatively unfolded state of the proteasome-specific inhibitor, clasto-lactacystin that promotes the generation of p50 (see model in Figure  ␤ -lactone, blocked the generation of p50. Prior studies 8A). In contrast, premature release of this 497-residue have demonstrated that replacement of C-terminal p105 polypeptide from the ribosome allows its complete foldsequences located downstream of the GRR have little ing, which effectively abrogates p50 production. effect on p50 generation (Betts and Nabel, 1996; Lin Second, progressive repositioning of the stop codon and Ghosh, 1996). Our results now provide a potential in the p105 mRNA revealed that translation to a point explanation for these results. Although the proteasome between amino acids 514 and 530 permitted p50 generexclusively utilizes substrates that are unfolded, the paration to occur in vivo (Figure 3 ). Relating this finding to ticular structure of the nascent p105 fragment may make the results obtained in the ribosome-halting experiment it an acceptable substrate for the proteasome. Specifically, the loosely structured GRR may form a proximal (Figure 2) , we suggest that the time, rather than distance, of p105 during p50 generation could be explained in one of two ways. First, translation of the C terminus of p105 may be interrupted during proteasome-mediated processing of p50, and thus the C terminus is never made. Second, the C terminus may be translated, but it may be continuously channeled into the barrel of the proteasome and rapidly degraded.
NF-B p105 and p50 Do Not Exhibit a Precursor-Product Relationship
The pulse-chase radiolabeling studies (Figure 1 ) and our other findings clearly argue against a classical precursor-product relationship for p105 and p50. Functional studies of p105 and p50 have highlighted their different biological functions within the cell, with p50 acting as a Rel-related transcription factor (Ghosh et al., 1990; Kieran et al., 1990 ) and p105 serving as a specific cytoplasmic inhibitor of Rel proteins (Rice et al., 1992; Naumann et al., 1993) . In contrast to Rel complexes sequestered by IB-␣ in which this inhibitor is subject to signal-induced complete degradation by the proteasome (Henkel et al., 1993; Chen et al., 1995; Lin et al., 1995; Traenckner et al., 1995) , Rel complexes sequestered by p105 are not rapidly mobilized to the nucleus in response to these same signals (Mercurio et al., 1993; Sun et al., 1994; Donald et al., 1995) . While the biological In contrast to our studies incorporating both in vitro and in vivo approaches, the generation of p50 has previously been suggested based on in vitro analyses to portion of a peptide loop that inserts through the 13-Å diameter orifice of the proteasome into its barrel, involve posttranslational processing of p105 (Palombella et al., 1994) . We suspect that the biological basis allowing processing to proceed (see model in Figure  8C ; for structure of the proteasome, Goldberg, 1995;  for p50 generation in the previous experimental setting (Palombella et al., 1994; Orian et al., 1995) and our sys-Lö we et al., 1995; Weissman et al., 1995) .
It remains unclear whether translation of the C termitem are in fact rather similar. Specifically, the in vitro system utilized in the earlier studies may promote a nus of p105 continues or is interrupted when p50 is produced. Despite extensive efforts, the C-terminal fragsignificant degree of posttranslational unfolding that recapitulates the conformation of the nascent polyment of the processed NF-B1 gene product has never been detected (Hatada et al., 1992; Lin and Greene, peptide, thereby allowing processing by the 26S proteasome. Whereas ubiquitination is required for the obunpublished data). While a C-terminal fragment, termed IB-␥, has been detected in certain mouse B cell lines, served posttranslational processing of p105 (Palombella et al., 1994; Orian et al., 1995) , it is not clear whether this protein is apparently produced by alternate mRNA splicing rather than p105 processing (Inoue et al., 1992;  ubiquitin plays any requisite role in the cotranslational processing that we have described.
Liou et al., 1992). Lack of detection of the C terminus

How Is the GRR Involved in Cotranslational
cells and for the selective degradation of certain proteins under specific physiological conditions (for reviews, Generation of p50? A 23-amino acid glycine-rich region (GRR) was pre- Rechsteiner et al., 1993; Goldberg, 1995; Jentsch and Schlenker, 1995) . These functions invariably involve the viously identified as a critical element for the generation of p50 (Lin and Ghosh, 1996) . Consistent with this obsercomplete destruction of the target proteins. In contrast, for p105, cotranslational processing by the proteasome vation, we have found that deletion of the GRR in nascent p105-derived fragments results in the generation yields p50. Nascent p105 fragments may be prone to proteasome-mediated proteolysis for any of several reaof little or no p50 (data not shown). These findings thus demonstrate that the GRR is required for the cotranslasons. For example, these nascent forms might be particularly susceptible to ubiquitination, thereby becoming tional generation of p50. However, our studies have further shown that p105 proteins lacking the GRR continue preferential targets for the 26S proteasome like many other ubiquitinated proteins. The 26S proteasome correto associate with the proteasome (data not shown), indicating that this element does not function as a primary sponds to a complex consisting of the 20S proteasome and PA700 (also termed the 19S complex), which conproteasome targeting signal. While it is clear that many proteins are directed to the proteasome for degradation, tains ATPases, a polyubiquitin binding protein, and other regulatory proteins (Ma et al., 1994) . Alternatively, the emerging evidence suggests that some proteins may be targeted by virtue of a chaperone-like activity of the 26S proteasome may function as a chaperone that interacts directly with nonubiquitinated forms of nascent proteasome (Goldberg, 1995) . As previously demonstrated, the GRR effectively functions in the context of p105. This interaction may retain a portion of p105 in an unfolded conformation that favors proteolysis. Roles certain heterologous proteins (gp10-GRR-GST chimera; Lin and Ghosh, 1996) , whereas in other protein contexts for chaperone activity of the 26S proteasome have been hypothesized previously (Goldberg, 1995) but usually in (GST-GRR-gp10), no processing occurs (Lin and Greene, unpublished data) . This latter result may reflect a diminthe context of ATP-dependent unfolding of the substrate after it has been targeted to the 26S proteasome by ished affinity of the N terminus of this protein for the proteasome.
ubiquitination. Recently, however, we have obtained direct evidence for chaperone activity of isolated PA700 with nonubiquitinated misfolded proteins (DeMartino
NF-B p105 as a Natural Model of Sequential and Cotranslational Protein
and Thomas, unpublished data). Such results are consistent with a direct interaction of the 26S proteasome Folding in Eukaryotes Recently, Netzer and Hartl (1997) have proposed that with nascent forms of p105. Thus, even though our experiments have utilized inhibitors and antibodies against eukaryotic proteins undergo sequential and cotranslational folding. In contrast, prokaryotic proteins seem to the 20S proteasome, it is likely that p105 processing is catalyzed by the 26S proteasome. In fact, Sears and rely predominantly on a posttranslational mechanism of folding for the acquisition of full biological function.
Maniatis recently have identified two yeast mutants that fail to generate p50. These mutations occur in an ATPase These conclusions derive from the analysis of a fusion protein containing a human H-Ras domain at the N tersubunit and an isopeptidase subunit that are present in the PA700 subcomplex (Sears and Maniatis, personal minus joined by a glycine-rich segment to a mouse dihydrofolate reductase (DHFR) domain at the C terminus. communication), thus providing additional support for a role of the 26S form of the proteasome in generation In these studies, the H-Ras domain was found to fold prior to synthesis of the DHFR polypeptide. Like this of p50. Appreciable evidence now indicates a close functional link between protease activity and chaperone artificial fusion protein, p105 contains two functionally independent domains linked by the GRR. Further, p50 activity in several systems, including the Escherichia coli ClpAP and XP proteases (Gottesman et al., 1997 ; is generated from the N terminus prior to the completion of C-terminal translation. We suspect that the N-terminal Suzuki et al., 1997) and the yeast PIM1 protease (Wagner et al., 1994) . Like the 26S proteasome, each of these Rel homology domain within p50 may undergo cotranslational folding and thus allow this region of the protein enzymes is a large ATP-dependent protease complex and may couple ATPase activity to a process required to escape proteasome-mediated degradation. Additionally, such N-terminal folding may also promote rapid for proteolysis. Additional work will be required to deterdownstream folding (as supported by stop codon scan mine whether cotranslational processing of proteins by experiments shown in Figure 3) , leading to the producprotease-chaperones is a widespread process. tion of p105 rather than p50. Evolutionarily, the different Received December 31, 1997; revised February 9, 1998. using the LipofectAMINE reagent (GIBCO BRL). After overnight incubation, the cells were washed in phosphate-buffered saline and incubated for 1 hr at 37ЊC in RPMI 1640 lacking methionine and References cysteine (Mediatech). Subsequently, the cells were pulse-radiolabeled by the addition of 200 Ci/ml of [ 35 S]methionine/cysteine (Du- Baeuerle, P.A., and Baltimore, D. (1988) . IB: a specific inhibitor of Pont NEN) for various periods of time and chased by removal of the NF-B transcription factor. Science 242, 540-545. the radiolabeled amino acids and addition of RPMI 1640 medium Baeuerle, P.A., and Baltimore, D. (1996) . NF-B: ten years after. Cell containing cycloheximide (12.5 g/ml, Sigma). After defined periods 87, 13-20. of pulse or chase, the cells were lysed on ice in ELB buffer (300 Baeuerle, P.A., and Henkel, T. (1994 (1995) . Signal-induced site-specific phostimes. In experiments requiring synchronization of translation, aurinphorylation targets IB␣ to the ubiquitin-proteasome pathway. tricarboxylic acid (Sigma) was added to a final concentration of 75 Genes Dev. 9, 1586-1597. M 3 min after the initiation of translation (Frydman et al., 1994) . Stop buffer (20 mM Tris-HCl [pH 7.5], 5 mM MgCl 2 , 1 mM ATP, and Craiu, A., Gaczynska, M., Akopian, T., Gramm, C.F., Fenteany, G., Goldberg, A.L., and Rock, K.L. (1997) . Lactacystin and clasto-lacta-2 mM puromycin) was added to the samples followed by incubation at 25ЊC for 5-10 min prior to immunoprecipitation.
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